Holen Sie sich die Stockscreener-App
4.5185
1.23%
-0.0565
Schlusskurs vom Vortag:
$4.575
Offen:
$4.49
24-Stunden-Volumen:
3,295
Relative Volume:
0.11
Marktkapitalisierung:
$5.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.30M
KGV:
-0.5546
EPS:
-8.148
Netto-Cashflow:
$-8.01M
1W Leistung:
-3.86%
1M Leistung:
-8.72%
6M Leistung:
+16.16%
1J Leistung:
+6.07%
1-Tages-Spanne:
$4.345
$4.60
1-Wochen-Bereich:
$4.05
$4.725
52-Wochen-Spanne:
$2.96
$9.85
Endra Life Sciences Inc Stock (NDRA) Company Profile
Firmenname
Endra Life Sciences Inc
Sektor
Branche
Telefon
734-335-0468
Adresse
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.60 | 6.07M | 0 | -7.30M | -8.01M | -8.148 |
TMO
Thermo Fisher Scientific Inc
|
587.81 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.03 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
589.30 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
321.43 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
144.81 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
ENDRA Life Sciences Inc (NDRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ENDRA Life Sciences Inc (NDRA) Balance Sheet - TradingKey
ENDRA Life Sciences Inc (NDRA) Cash Flow - TradingKey
ENDRA Life Sciences Inc (NDRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NDRA|ENDRA Life Sciences Inc|Price:4.750|Chg%:-0.110 - TradingKey
ENDRA Life Sciences Inc (NDRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ENDRA Life Sciences Inc (NDRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ENDRA Life Sciences Inc. Revenue Breakdown – NASDAQ:NDRA - TradingView
ENDRA Life Sciences Inc (NDRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
ENDRA Life Sciences Inc (NDRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
NDRA|ENDRA Life Sciences Inc|Price:4.860|Chg%:-0.370 - TradingKey
ENDRA Life Sciences Inc (NDRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ENDRA Life Sciences (NDRA) Advances 4.66% as Shares Test Resistance Near $5.89Fundamental Weighted - dars.gov.et
ENDRA Life Sciences (NDRA) News Flow - Moomoo
ENDRA Life Sciences Inc (NDRA) Fundamental & Financial Data - Stocktwits
Noble Africa-ENDRA (NDRA) merger to create pure-play helium and LNG company - Stock Titan
ASP Isotopes (NDRA) outlines Noble Africa–ENDRA merger and $750M project funding - Stock Titan
ASP Isotopes maps Noble Africa listing as helium project nears production - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company - marketscreener.com
Frontier tech research, news & data - MLQ.ai
ENDRA Life Sciences agrees to merge with ASP Isotopes unit Noble Africa in deal set to create Nasdaq-listed NOBA - Bitget
ASP Isotopes and ENDRA (NASDAQ: NDRA) plan Noble Africa helium spin-out - Stock Titan
ENDRA Life Sciences (NASDAQ: NDRA) details Noble Africa merger and helium strategy - Stock Titan
Noble Africa's helium project could become a Nasdaq-listed company - Stock Titan
NDRA Q1 2026 Earnings: Wider-than-Expected Loss Amid No Revenue, Stock Rises SlightlyOperating Margin Analysis - DonanımHaber
ENDRA Life Sciences (NDRA) Files 8-K Report: Company Information, NASDAQ Listing, and Corporate Details - Minichart
ENDRA Regains Nasdaq Compliance, Enters One-Year Monitoring - TipRanks
END regains Nasdaq compliance but faces one-year discretionary panel monitoring - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) regains Nasdaq listing compliance but faces review - Stock Titan
NDRA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Faces Headwinds - dars.gov.et
ENDRA Life Sciences Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Stage ContinuesTangible Book Value - dars.gov.et
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA - Sahm
NDRAENDRA Life Sciences Inc Latest SEC Filings - Finviz
ENDRA Life Sciences (NDRA) Stock Analysis Report | Financials & Insights - Benzinga España
Halper Sadeh LLC investigates if BOLD and NDRA mergers offer fair deals to shareholders. - Pluang
ASP Isotopes' Noble Africa unit to merge with ENDRA Life Sciences unit in $50M deal - MSN
ASP Isotopes announces Noble Africa merger with ENDRA Life Sciences alongside 50 million dollar financing - Traders Union
ENDRA (NDRA) director commits 9.99% stake to support Noble Africa merger - Stock Titan
ENDRA Life Sciences Inc. (NDRA) Holds Steady Near Flatline as Support Level Holds FirmIchimoku TK Cross - dars.gov.et
ASP Isotopes to merge Noble Africa with a unit of ENDRA – a look at the key contours of the deal - MSN
Enterprise value to EBITDA forward of ENDRA Life Sciences Inc. – NASDAQ:NDRA - TradingView
ASP Isotopes And ENDRA Life Sciences Announce Proposed Noble Africa Merger And $50 Million Financing - Pulse 2.0
📈💲📈💲📈💲📈💲📈💲📈 - Moomoo
Price to earnings forward of ENDRA Life Sciences Inc. – NASDAQ:NDRA - TradingView
Enterprise value to revenue forward of ENDRA Life Sciences Inc. – NASDAQ:NDRA - TradingView
Strategic Merger Brings Rare Helium & LNG Platform to Global Investors as Renergen, ENDRA, and ASPI Unite - Minichart
ENDRA Life Sciences to Merge, Rebrand as Noble Africa - TipRanks
ENDRA (NDRA) to merge, raise ~$50M and rebrand as Noble Africa Inc. - Stock Titan
ENDRA (NASDAQ: NDRA) sets Noble Africa merger and $50M Noble investment - Stock Titan
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):